Browse by People

Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 6.

Rajeev, S, Sprung, VS ORCID: 0000-0002-2666-4986, Roberts, C ORCID: 0000-0003-4275-601X, Harrold, JA ORCID: 0000-0002-0899-4586, Halford, JCG, Stancak, A, Boyland, E ORCID: 0000-0001-8384-4994, Kemp, GJ ORCID: 0000-0002-8324-9666, Cuthbertson, D ORCID: 0000-0002-6128-0822 and Wilding, J ORCID: 0000-0003-2839-8404
(2017) Compensatory changes in energy balance during dapagliflozin treatment in type 2 diabetes mellitus: A randomised double-blind, placebo-controlled, cross-over trial (ENERGIZE)- study protocol. BMJ Open, 7 (1).

Wilding, J ORCID: 0000-0003-2839-8404, Bailey, C, Rigney, U, Blak, B, Kok, M and Emmas, C
(2017) Dapagliflozin therapy for type 2 diabetes in primary care: Changes in HbA1c, weight and blood pressure over 2 years follow-up. PRIMARY CARE DIABETES, 11 (5). 437 - 444.

Wilding, J ORCID: 0000-0003-2839-8404, Zourikian, N, Di Minno, M, Khair, K, Marquardt, N, Benson, G, Ozelo, M and Hermans, C
(2018) Obesity in the global haemophilia population: prevalence, implications and expert opinions for weight management. OBESITY REVIEWS, 19 (11). 1569 - 1584.

Psarou, A
(2017) Type 2 diabetes patients and their body weight: A mixed methods study investigating beliefs, attitudes, and adherence to their medicines over time. PhD thesis, University of Liverpool.

Bing, C, Ding, C and Wilding, J ORCID: 0000-0003-2839-8404
(2016) Vitamin D3 analogues ZK159222 and Zk191784 have anti-inflammatory properties in human adipocytes. Endocrinology, Metabolsim & Genetics.

Cuthbertson, D ORCID: 0000-0002-6128-0822, Steele, T, Wilding, J ORCID: 0000-0003-2839-8404, Halford, JCG, Harrold, JA ORCID: 0000-0002-0899-4586, Hamer, M and Karpe, F
(2017) What have human experimental overfeeding studies taught us about adipose tissue expansion and susceptibility to obesity and metabolic complications? International Journal of Obesity, 41. 853 - 865.

This list was generated on Wed Jun 9 06:48:45 2021 BST.